Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,341
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,860
Class I recallsReasonable probability of serious health consequences
24,450
Class II recallsTemporary or medically reversible health consequences
2,901
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,095 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,739 recalls have been announced year to date.
  • Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (300).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,450
Class I9,860
Class III2,901
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,450
Class I9,860
Class III2,901
Not Yet Classified2

Showing 7,961–7,980 of 17,454 recalls

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

HYDROXOCOBALAMIN 1000 MCG/ML (MDV), 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0926-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

HYDROXOCOBALAMIN 1000 MCG/ML (PFV), 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0949-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

HYDROMORPHONE 0.2MG/ML IN NACL 0.9% SYR (C-II) , [a) 50 ML NDC 70731-0114-89; b) 55 ML NDC 70731-0114-95] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

HYDROGEN PEROXIDE 3% INJECTABLE PFV, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0907-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

GLUTATHIONE 200MG/ML (MDV) INJECTION SOLN, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0906-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

FOLIC ACID 10MG/ML INJECTION SOLUTION (MDV), 5 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0921-05

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

FENTANYL 2MCG/ML BUPIVACAINE 0.125% IN NACL 0.9% SRY C-II, 50ML per syringe (C-II) RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0207-89

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

fentaNYL 0.05MG/ML INJ SOL (PF), 55ML per syringe (C-II) RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0118-55

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

EPINEPHrine 4MG ADDED TO D5W 5%, 250 ML per bag, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0113-22

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

EPHEDRINE 5MG/ML (PF) SYRINGE, 5 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0201-85

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

Edetate Disodium150mg/mL PFV, 10 ML per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0934-11

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

EDETATE DISODIUM 15% INJECTABLE, 100 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0922-11

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

EDETATE DISODIUM 30% INJECTABLE, 100 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0931-11

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

diazePAM 5 MG/ML INJECTION SOLUTION (C-IV) SYR, 2 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0929-02

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

DEXTROSE 50% INJECTION SOLUTION (PF) VIAL, 50 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0969-89

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

DEXTROSE 50% INJECTION SOLUTION (PF) SYRINGE, 50 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0969-89

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

DEXPANTHENOL 250MG/ML (MDV) INJECTION SOLN, 30ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0932-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

CALCIUM GLUCONATE 5% INJECTION SOLUTION (MDV), 20 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0903-20

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

CALCIUM CHLORIDE 100MG/ML (PFV) INJ SOLN, 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0920-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

BUFFERED LIDOCAINE HCL 1% INJECTION SOL (PF) SYR, 0.5 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0139-84

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.